Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

AI can improve early diagnosis and classification of PCOS, aiding in prevention of related health issues.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.